AGEN Agenus Inc: Earnings per share for the last twelve months

Official company branding of Agenus (AGEN)

Agenus develops innovative antibodies to combat cancer, which opens prospects for lucrative licensing. However, FDA rejections and liquidity shortages have created serious financial risks. The company's expertise in immuno-oncology confirms its medical authority. The trailing 12-month earnings per share trend on the GURU.Markets chart shows that the metric is holding at 0.73.

Agenus (AGEN) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/13/2026

Analytical breakdowns and data insights for company Agenus, Inc. (AGEN)

- current quotes and average value forecast:
Price Chart Agenus|AGEN - Consensus Target
- company stock capitalization data:
Market Value Agenus Inc.|AGEN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Agenus|AGEN - Book Capitalization|Market Value to Book Value Ratio agenusbio.com|AGEN - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Agenus|AGEN - Long-Term Liabilities to Capital|Short-Term Debt to Capital Agenus Inc|AGEN - Company Aggregate Debts|Debts to Book Capitalization Agenus Inc.|AGEN - Long-Term Indebtedness|Company Short-Term Debts Agenus|Quick Liquidity agenusbio.com
- earnings and valuation multiples indicators:
AGEN - Company Profit|Future Profit Agenus|AGEN - P/E Multiple|Future Price to Earnings Agenus Inc.|AGEN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Agenus Inc.|AGEN - Operating profit EBITDA|Net earnings per share (EPS TTM) Agenus|AGEN - Net earnings per share for the trailing year|Quarterly EPS earnings growth agenusbio.com|AGEN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Agenus
Analysis of all company metrics:Agenus (AGEN)
Manufactured products of Agenus, Inc.

This indicator measures the aggregate net income of Agenus (AGEN) over the last four quarters distributed per common share, allowing for an assessment of the actual efficiency of capital generation. By analyzing the rolling earnings per share (EPS) metric, an investor can gauge the financial stability of Agenus (AGEN) amid the automation of drug synthesis via AI and high clinical trial costs.

Analysis of competing companies

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BCRX - Net earnings per share (EPS TTM)|VERA: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year dianthustx.com DNTH|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AbCellera Biologics Inc ABCL|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Precigen Corp - Earnings per share for the last 12 months|Pharming Group N.V. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) nektar.com NKTR|UPB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Zenas Bio ZBIO|IMNM: Net earnings per share (EPS TTM)|Gossamer Bio Corp. (GOSS) - Net earnings per share (EPS TTM)|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|SEPN - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) PVLA|SVRA - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rigel Pharmaceuticals Inc RIGL|ANAB: Earnings per share for the last 12 months|ATXS - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ENGN|RAPT: Net earnings per share (EPS TTM)|Aerovate Therapeutics - Earnings per share for the trailing year|ACRS (Aclaris) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Kyverna Therapeutics, Inc|Earnings per share for the last twelve months Tiziana Life Sciences (TLSA)|CABA (cabalettabio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|THTX - Net earnings per share for the last 12 months|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|CLYM (Climb Bio Inc) - Net earnings per share for the last 12 months|Zura Bio Ltd - Earnings per share for the trailing year|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|Adagene Corp (ADAG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months ImageneBio Inc (IMA)|Net earnings per share for the last 12 months shattucklabs.com STTK|Earnings per share for the last twelve months Equillium EQ|CNTB - Net earnings per share for the last 12 months|IMUX: Net earnings per share for the last 12 months|ATRA - Net earnings per share (EPS TTM)|inflarx.de (IFRX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months XFOR|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Celularity Corp CELU|Net earnings per share (EPS TTM) INMB|Net earnings per share (EPS TTM) Barinthus Biotherapeutics PLC (BRNS)|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share for the trailing year SAB Biotherapeutics Inc|Akari Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enlivex Therapeutics|q32bio.com (QTTB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months GOVX|Net earnings per share for the last 12 months EDSA|Net earnings per share (EPS TTM) iBio Corporation|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|Net earnings per share for the last four quarters xtlbio.com|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share (EPS TTM) HCW Biologics, Inc. HCWB|Aptevo - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year AIM ImmunoTech, Inc. (AIM)|ADTX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months gribio.com (GRI)|Earnings per share for the last twelve months XORTX Therapeutics|Earnings per share for the last 12 months HIND (Vyome Holdings Inc.)|Earnings per share for the last twelve months Revelation Bio (REVB)|INDP: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|Earnings per share for the trailing year CALI|Affimed Therapeutics - Net earnings per share (EPS TTM)|ALLK - Net earnings per share (EPS TTM)|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|IGM Biosciences - Earnings per share for the trailing year|Earnings per share for the last twelve months iTeos Therapeutics|Net earnings per share for the last 12 months oceanbiomedical.com (OCEA)|Net earnings per share (EPS TTM) TCBP|Net earnings per share (EPS TTM) Third Harmonic Bio Inc. (THRD)